Channels :: FRELIP Discovery

Author: Grobbelaar, Melanie

Quick Look
Resistance to the novel nitroimidazole drug class in Mycobacterium tuberculosis

Similar Items: Resistance to the novel nitroimidazole drug class in Mycobacterium tuberculosis

Quick Look
Development of a drug discovery protocol through the expression of key mycothiol biosynthetic enzymes for Mycobacterium tuberculosis
Quick Look
Pyrazinamide resistance in Mycobacterium tuberculosis
Quick Look
Deciphering the physiology of drug tolerant and resistant Mycobacterium tuberculosis
Quick Look
Mechanisms of resistance to new generation anti-TB drugs
Quick Look
Clinically relevant mutations contributing to drug resistance in Mycobacterium tuberculosis
Quick Look
The antimycobacterial activity of phytocannabinoids
Quick Look
Defining the role of efflux pump inhibitors on anti-TB drugs in Rifampicin resistant clinical Mycobacterium Tuberculosis isolates
Quick Look
Evaluation of rapid low-cost colorimetric methods for diagnosis of multidrug-resistant tuberculosis in limited-resource settings
Quick Look
Characterisation of phenotypic and genotypic resistance to new and re-purposed tuberculosis drugs in the Western Cape, South Africa
Quick Look
Overexpression of mmpS5/mmpL5 in Mycobacterium tuberculosis reduces susceptibility to anti-tuberculosis drugs
Quick Look
Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children
Quick Look
Deciphering the mechanisms of Isoniazid reisistance to mycobacterium tuberculosis
Quick Look
A pharmacometric approach to optimal use of second line drugs for multidrug-resistant tuberculosis
Quick Look
The development and validation of an LC-MS/MS method for the quantification of ertapenem in human plasma: application to paediatric XDR-TB case studies
Quick Look
Resistance to new tuberculosis drugs
Quick Look
Effect of pharmacological modulation of myeloid-derived suppressor cell function on immune reactivity against mycobacterium tuberculosis.
Quick Look
Accuracy and impact of the MTBDRplus v2 and MTBDRsl v2 line probe assays for the detection of first-line and second-line drug resistant tuberculosis
Quick Look
Investigating the host-directed therapeutic potential of curdlan-functionalised PLGA nanoparticles in the treatment of intracellular Mycobacterium tuberculosis
Quick Look
Determination of the transcriptomic effects and compensatory role ofF INHA C-15T promoter mutation in mycobacterium tuberculosis.
Quick Look
Defining mechanisms that determine the levels of drug resistance in Mycobacterium tuberculosis
Quick Look
Regulation of efflux in rifampicin resistant mutants of Mycobacterium tuberculosis
Quick Look
Investigation of the activity of sulfonamide anti-bacterial drugs in Mycobacterium tuberculosis and the role of oxidative stress on the efficacy of these drugs
Quick Look
Targeted deep sequencing to detect heterogeneity in Mycobacterium tuberculosis populations
Quick Look
Determination of the mechanism of synergy of SQ109 with rifampicin and isoniazid in Mycobacterium smegmatis